GLP-1 RAs have demonstrated favorable trends toward improving endocrine and metabolic outcomes, including reductions in ALT, AST, HbA1c, body weight, BMI, LFC, and IHA
The single-molecule approach (tirzepatide, retatrutide) offers advantages in simplicity and potentially in pharmacokinetics
NEJM, July 2025 Source: SURMOUNT-5 NEJM 2025 (safety data) Source: MHRA Updated semaglutide guidance (GOV.UK, February 2026) The content on the SheMed blog is provided for general informational and educational purposes only
How does diet and lifestyle help with weight management
D., Diamant Z., Hanania N
Although 5-Amino-1MQ is frequently mentioned with peptides and other substances that improve performance, it is not a peptide in the traditional sense